(Q95818649)
Statements
The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer (English)
Isabel Chu
Kimberly Blackwell
Susie Chen